Lars Hein Jensen

Lars Hein Jensen is an experienced professional in the field of medical writing and regulatory affairs, currently serving as Associate Director of Medical Writing at Genmab since June 2021. Previously held the position of Senior Medical Writing Manager at Genmab and Senior Medical Writer at Y-mAbs Therapeutics, Inc., where expertise included areas such as biotechnology, paediatric oncology, and immunotherapy. Lars also contributed to the regulatory processes at Novo Nordisk A/S for nearly a decade, focusing on Common Technical Documents for market authorization applications. Earlier roles included a Regulatory Professional position within Novo Nordisk A/S, dealing with life cycle management and regulatory strategy, as well as a Medical Writer role at Spadille Clinical Trials. Lars Hein Jensen earned a degree from Danmarks Farmaceutiske Universitet between 1994 and 2000.